Dipharma Francis Srl, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VORTIOXETINE HYDROBROMIDE MONOHYDRATE, with a corresponding US DMF Number 31618.
Remarkably, this DMF maintains an Active status since its submission on April 06, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 02, 2017, and payment made on April 05, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II